Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...
While autologous hematopoietic stem cell transplantation (aHSCT) has shown promise as a one-time treatment option for relapsing-remitting multiple sclerosis (RRMS), it’s still unclear what role aHSCT ...
Five separate mediation analyses found that adaptive coping had a significant association with each PWB subscale and self-efficacy. After controlling for self-efficacy, there remained separate ...
Be ready for the possible transition from RRMS to SPMS by understanding new symptoms, treatment options, and what to discuss ...
Basel, 16 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the United States Food and Drug Administration (U.S. FDA) has approved OCREVUS ZUNOVO™ (ocrelizumab & hyaluronidase-ocsq) ...
Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...
Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, ...
A prospective study found evidence of serum neurofilament light (sNfL) level increases in patients affected by active forms of relapsing-remitting multiple sclerosis (RRMS); however, these findings ...
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of ...
– At Week 144, 92.3% of Patients Remained Free of 12-Week Confirmed Disability Worsening (CDW) With 92.7% Remaining Free of 24-Week CDW – – Vidofludimus Calcium Continues to Demonstrate Favorable ...
Please provide your email address to receive an email when new articles are posted on . Study examined 41 individuals with RRMS and 20 healthy controls required to wear accelerometer for 1 week.
Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) ...